MINNEAPOLIS/ST. PAUL (08/20/2024) — Published in JCI Insight, a research team led by the University of Minnesota Medical School has identified small molecules that can reduce the production of proteins linked to age-related macular degeneration, or AMD, — the leading cause of irreversible vision loss among seniors in industrialized nations. Worldwide, AMD affects over 200 million people.  

"To our knowledge, this is the first demonstration of a small molecule preventing AMD-like pathology in our preclinical model. In the big picture, these results provide hope that AMD may indeed be preventable, or at least modifiable by administration of a single drug," said John Hulleman, PhD, an associate professor and Larson Endowed Chair for Macular Degeneration Research at the U of M Medical School and corresponding author.

By using unbiased drug screening, these inhibitors — specifically targeting a cellular pathway known as GSK3 — were found to prevent AMD features in a preclinical model. The results show that blocking GSK3 at low levels changes certain proteins linked to AMD, effectively preventing the disease in living organisms. 

Future research will focus on determining whether blocking GSK3 can reverse existing AMD damage, potentially leading to new treatment options. 

Funding was provided by the Fichtenbaum Charitable Trust, Roger and Dorothy Hirl Endowed Research Fund, Edward N. and Della L. Thome Memorial Foundation Award in Age-Related Macular Degeneration Research and National Institutes of Health grants [R01-EY027785, P30-EY030413, S10OD026758-01]. Additional support came from the Promega Advanced Academic Access Program.

###

About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. We acknowledge that the U of M Medical School is located on traditional, ancestral and contemporary lands of the Dakota and the Ojibwe, and scores of other Indigenous people, and we affirm our commitment to tribal communities and their sovereignty as we seek to improve and strengthen our relations with tribal nations. For more information about the U of M Medical School, please visit med.umn.edu

For media requests, please contact:
Ezra Xiong
Communications Specialist
xion1913@umn.edu
University of Minnesota Medical School